Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum OXiGENE OXGN

"OxiGene Inc is a biopharmaceutical company. The Company is engaged in the development of vascular disrupting agents, or VDAs, for the treatment of cancer. It is currently developing two clinical stage investigational drugs, both VDAs- CA4P and OXi4503."

NDAQ:OXGN - Post Discussion

OXiGENE > OXGN
View:
Post by david39 on Jul 15, 2010 6:01am

OXGN

Our recent pick OXGN was a big winner on Wednesday. As people pointed out in the morning, this stock had the potential for a good bounce play. Investors could have bought OXGN at its low of
.295 in the morning and sold some of it in the afternoon at its high of
.379. That is a gain of 28.5%. Volume remains strong and the positive close at
.35 is a good indication that people should see a strong open this morning.
Comment by thomson25 on Jul 15, 2010 6:10am
OXGN is up at 0.350 cents by 12.44%.
Comment by tonyclark126 on Jul 15, 2010 6:17am
OXGN is flying and I want you to keep it n your watch list.
Comment by mikejohnson21 on Jul 15, 2010 6:23am
OXGN is really moving well and I am very bullish on it.
Comment by Jamescarter54 on Jul 15, 2010 6:31am
OXGN is going up so keep an eye on it.